Patent · US Active

Compositions and methods for inducing cell dedifferentiation

US8309555B2 · kind B2 · utility

4Cited by
8References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 21, 2009
Grant dateNov 13, 2012
Priority date
Expiry dateDec 9, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D473/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides 2,6-disubstituted purine compounds, compositions and methods for dedifferentiating lineage committed mammalian cells into stem cells. The present invention also provides methods of inducing dedifferentiation of lineage committed mammalian cells into stem cells, which can be further differentiated into various lineage committed cells. Methods of identifying additional 2,6-disubstituted purine compounds useful for inducing dedifferentiation of lineage committed cells into stem cells are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.